SafeBeat Rx is a startup founded in 2020, operating in the Hardware and Health Care industries. The company's slogan, "Mobile software enhances cardiac therapeutics monitoring for optimal heart health," encapsulates its focus on leveraging technology for better heart health. In November 2023, the company secured a $10.00K grant investment from LG Nova. This investment signifies confidence from a notable investor in SafeBeat Rx's potential to make a positive impact in the healthcare sector. The grant will likely fuel the startup's efforts to advance its mobile software and further its mission of optimizing cardiac therapeutics monitoring. With this recent investment, SafeBeat Rx is poised to continue its trajectory toward innovative solutions in cardiac healthcare technology.
SafeBeat Rx
Mobile software enhances cardiac therapeutics monitoring for optimal heart health.
General Information
BounceWatch is an independent company data service, not affiliated with SafeBeat Rx. To contact SafeBeat Rx, visit safebeat.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About SafeBeat Rx
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $10.00K | 1 |
|
29 Nov 2023 |
| Non Equity Assistance | Undisclosed | 1 |
|
07 Jun 2022 |
| Pre Seed Round | $125.00K | 2 |
|
31 Aug 2021 |
SafeBeat Rx Alternatives & Competitors
-logo.jpg "Bright Technology (Liangdong)"){kind=logo}
Empowering you with heart health insights through innovative monitoring solutions.
Subscription-based service for customized heart health tracking.
Continuous non-invasive monitoring for heart failure patients. Making reactive healthcare proactive.
FAQ About SafeBeat Rx
Source: BounceWatch company record for SafeBeat Rx, https://bouncewatch.com/company/safebeat-rx, updated 31 December 2024. When citing, please name BounceWatch and link this page.
